We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
-7.89%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
-$29.7M
Cap. Flow
+$110M
Cap. Flow %
10.28%
Top 10 Hldgs %
55.73%
Holding
349
New
26
Increased
163
Reduced
134
Closed
15

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$35.5M
2
GRAB icon
Grab
GRAB
+$33.3M
3
QCOM icon
Qualcomm
QCOM
+$25.7M
4
AMD icon
Advanced Micro Devices
AMD
+$21.8M
5
SE icon
Sea Limited
SE
+$18.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.29%
2 Technology 26.19%
3 Communication Services 11.91%
4 Healthcare 11.24%
5 Real Estate 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCID icon
276
Lucid Motors
LCID
$2.46B
$236K 0.02%
1,689
+96
+6% +$16.6K
HPQ icon
277
HP
HPQ
$23.5B
$230K 0.02%
9,248
-1,848
-17% -$56.8K
CDMO
278
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$229K 0.02%
11,979
-2,015
-14% -$36.7K
ARQT icon
279
Arcutis Biotherapeutics
ARQT
$3.42B
$228K 0.02%
+11,947
New +$271K
BSX icon
280
Boston Scientific
BSX
$65.8B
$228K 0.02%
5,875
+382
+7% +$15.3K
ENTA icon
281
Enanta Pharmaceuticals
ENTA
$372M
$227K 0.02%
4,381
-1,939
-31% -$113K
IT icon
282
Gartner
IT
$9.41B
$225K 0.02%
812
-38
-4% -$10.7K
MYGN icon
283
Myriad Genetics
MYGN
$530M
$225K 0.02%
11,783
-698
-6% -$16K
VCEL icon
284
Vericel Corp
VCEL
$2.3B
$225K 0.02%
9,701
-1,796
-16% -$49K
GLW icon
285
Corning
GLW
$126B
$222K 0.02%
7,638
-359
-4% -$12.2K
SCHW
286
Charles Schwab
SCHW
$177B
$222K 0.02%
+3,092
New +$215K
ZS icon
287
Zscaler
ZS
$23B
$221K 0.02%
1,347
INO icon
288
Inovio Pharmaceuticals
INO
$79.8M
$220K 0.02%
10,640
-3,316
-24% -$84.9K
MCK icon
289
McKesson
MCK
$98.5B
$219K 0.02%
+645
New +$224K
MS icon
290
Morgan Stanley
MS
$337B
$219K 0.02%
2,769
-10
-0.4% -$843
T icon
291
AT&T
T
$165B
$217K 0.02%
14,163
-52
-0.4% -$946
LGND icon
292
Ligand Pharmaceuticals
LGND
$6.02B
$216K 0.02%
4,012
-1,151
-22% -$67.7K
ICPT
293
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$216K 0.02%
15,508
-2,051
-12% -$33K
COGT icon
294
Cogent Biosciences
COGT
$6.79B
$215K 0.02%
+14,390
New +$197K
SIRI icon
295
SiriusXM
SIRI
$10B
$215K 0.02%
3,761
EW icon
296
Edwards Lifesciences
EW
$47.6B
$213K 0.02%
2,575
+278
+12% +$26.8K
RGNX icon
297
Regenxbio
RGNX
$623M
$213K 0.02%
8,055
-912
-10% -$27.1K
CDW icon
298
CDW
CDW
$17.1B
$212K 0.02%
1,357
-63
-4% -$10.8K
SPGI icon
299
S&P Global
SPGI
$126B
$210K 0.02%
687
-4
-0.6% -$1.43K
EPAM icon
300
EPAM Systems
EPAM
$4.69B
$208K 0.02%
+573
New +$219K

Similar funds

E Fund Management's Q3 2022 Portfolio in Review

As of Q3 2022, E Fund Management held 349 positions worth $1.07B, down 2.7% from $1.1B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

E Fund Management deployed $110M of net new capital in Q3 2022, opening 26 new positions and adding to 163 existing holdings. Its largest new stake was TSMC: 430,000 shares worth $29.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, down from 36% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Mercado Libre, an estimated $26.6M trimmed.

  • E Fund Management's largest Q3 2022 buy was TSMC: 430,000 shares worth $29.5M.
  • E Fund Management added most to Grab in Q3 2022, an estimated $33.3M increase.
  • E Fund Management's biggest Q3 2022 reduction was Mercado Libre, cutting an estimated $26.6M.
  • E Fund Management fully exited DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share in Q3 2022, selling an estimated $6.5M.
  • E Fund Management's ten largest holdings make up 56% of its $1.07B portfolio in Q3 2022.
  • E Fund Management opened 26 new positions and closed 15 in Q3 2022.
  • E Fund Management's portfolio value fell 2.7% quarter-over-quarter to $1.07B.

Based on E Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.